Sanofi
€73.10Change from previous close: +0.63%Absolute change: +€0.46
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €87.58B
- Enterprise value
- €104.61B
- P/E (trailing 12 months)
- 22.6
- Forward P/E
- 8.05
- PEG
- 27.6
- Price/book
- 1.27
- Price/sales
- 1.79
- EV/EBITDA
- 7.73
- EV/revenue
- 2.14
Profitability and growth
- Gross margin
- 73.5%
- Operating margin
- 21.0%
- Net margin
- 8.1%
- ROE
- 5.7%
- ROA
- 5.1%
- ROIC
- 9.1%
- Revenue growth (year over year)
- 14.6%
- Earnings growth (year over year)
- -91.2%
Financial health
- Total cash
- €6.35B
- Total debt
- €23.58B
- Debt/equity
- 0.34
- Current ratio
- 0.99
- Quick ratio
- 0.49
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- €4.12
- Dividend yield
- 5.7%
- Payout ratio
- 127.6%
- Ex-dividend date
- May 5, 2026
Analysts and estimates
- Average price target
- €94.06
- Median price target
- €95.00
- High price target
- €112.00
- Low price target
- €78.00
- Analysts with a price target
- 24
- Consensus
- Buy
- Forward EPS
- €9.08
- EPS estimate, current year
- €8.58
Shares and trading
- Beta
- 0.28
- Average volume
- 1.96M
- Shares outstanding
- 1.2B
- Float
- 1.08B
- Institutional ownership
- 42.5%
- Insider ownership
- 10.3%